Browsing: Therapeutics
Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY) agreed…
JHVEPhoto/iStock Editorial by way of Getty Photos Amgen (NASDAQ:AMGN) mentioned that the Federal Commerce Fee’s lawsuit to problem its deliberate…
Andrey Tolkachev Oncology drug developer Depth Therapeutics (NASDAQ:INTS) has upsized its proposed preliminary public providing to $15M from $8M. The…
Marvell Expertise GroupSupply: marvell.comTake a look at the businesses making headlines earlier than the bell:Marvell Expertise (MRVL) – The chip…
2nd illustrations and pictures Malaysian biotech CytoMed Therapeutics (GDTC) has filed for a proposed $15M preliminary public providing. CytoMed did…
GENEVA, SWITZERLAND / ACCESSWIRE / October 26, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Reduction”), immediately introduced that they and…
gorodenkoff TCR2 Therapeutics (NASDAQ:TCRR) stated its cell remedy gavo-cel confirmed medical profit in sufferers with mesothelin-expressing strong tumors in a…